Cambridge, MA, United States of America

Nuvalent, Inc.


USPTO Granted Patents = 7

Trademarks = 2

Forward Citations = 9

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Joshua Courtney Horan (7 out of 7 patents)

silverMedal Scot Richard Mente (5 out of 29 patents)

bronzeMedal Matthew D Shair (5 out of 23 patents)

4.  Henry Efrem Pelish (5 out of 12 patents)

5.  Anupong Tangpeerachaikul (5 out of 5 patents)

6.  Xinxing Tang (4 out of 4 patents)

7.  Baudouin Gerard (3 out of 9 patents)

8.  Sibao Chen (2 out of 5 patents)

9.  David James Pearson (2 out of 2 patents)

10.  Benjamin Stephen Lane (2 out of 2 patents)

11.  Jason T Kropp (2 out of 2 patents)

12.  Christopher G F Cooper (2 out of 2 patents)

13.  Kristin Lynne Andrews (1 out of 1 patent)

14.  Yuting Sun (1 out of 1 patent)


7 patents:

Company Overview
Nuvalent, Inc. is a biotechnology company focused on developing novel targeted therapies for cancer. With a team of experienced scientists and researchers, Nuvalent is dedicated to advancing precision medicine and improving outcomes for cancer patients. The company's innovative approach to drug discovery and development has the potential to revolutionize cancer treatment and make a lasting impact on the field of oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#295 in Cambridge, MA

#2,305 in Massachusetts

#39,879 in US

Cambridge, MA (US)
Cambridge, MA, United States of America
Forward Citations = 9

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nuvalent, Inc.. Retrieved from https://idiyas.com/company/nuvalent

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…